Axxcess Wealth Management, LLC Invitae Corp Transaction History

Axxcess Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$0.42 - $0.72 $637 - $1,093	-1,519 Reduced 4.03%	36,199 $22,000
Q3 2023 Nov 14, 2023	SELL	$0.6 - $1.53 $533 - $1,360	-889 Reduced 2.3%	37,718 $22,000
Q2 2023 Aug 08, 2023	BUY	$1.05 - $1.63 $1,391 - $2,159	1,325 Added 3.55%	38,607 $43,000
Q1 2023 May 03, 2023	BUY	$1.2 - $2.73 $4,047 - $9,208	3,373 Added 9.95%	37,282 $50,000
Q4 2022 Feb 14, 2023	SELL	$1.71 - $3.61 $23,346 - $49,287	-13,653 Reduced 28.71%	33,909 $63,000

Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $5,111 - $23,214	-2,690 Reduced 5.35%	47,562 $117,000
Q2 2022 Aug 11, 2022	BUY	$2.13 - $9.01 $13,870 - $58,673	6,512 Added 14.89%	50,252 $123,000
Q1 2022 Aug 11, 2022	SELL	$6.28 - $15.59 $41,058 - $101,927	-6,538 Reduced 13.0%	43,740 $349,000
Q4 2021 Aug 11, 2022	BUY	$14.7 - $28.67 $739,086 - $1.44 Million	50,278 New	50,278 $768,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Axxcess Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Axxcess Wealth Management, LLC with notifications on news.